River Rock Vision Center | |
127 Village Dr, Suite 300, Belgrade, MT 59714-9617 | |
(406) 388-9661 | |
(406) 388-9662 |
Full Name | River Rock Vision Center |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 127 Village Dr, Belgrade, Montana |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902077407 | NPI | - | NPPES |
0483701 | Medicaid | MT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 774 (Montana) | Primary |
Provider Name | Joseph K Parks |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1255493599 PECOS PAC ID: 8123084050 Enrollment ID: I20051121000359 |
News Archive
Biological tissues have evolved over millennia to be perfectly optimized for their specific functions. Take cartilage as an example. It's a compliant, elastic tissue that's soft enough to cushion joints, but strong enough to resist compression and withstand the substantial load bearing of our bodies: key for running, jumping, and our daily wear and tear.
Agriculture Secretary Mike Johanns and Interior Secretary Dirk Kempthorne has announced that their departments and the State of Alaska have tested more than 13,000 wild migratory birds for highly pathogenic avian influenza (HPAI) H5N1 in Alaska.
U.S. health care workers, especially doctors and nurses, use complementary and alternative medicine (CAM) far more than do workers in other fields, according to a new study. CAM includes diverse therapies outside the realm of conventional medicine.
"A summit designed to kickstart a joint effort by world leaders to address hunger and malnutrition will be held in London on 12 August to coincide with the closing day of the Olympics, the British government has announced," the Guardian reports.
Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
River Rock Vision Center 127 Village Dr, Suite 300, Belgrade, MT 59714-9617 Ph: (406) 388-9661 | River Rock Vision Center 127 Village Dr, Suite 300, Belgrade, MT 59714-9617 Ph: (406) 388-9661 |
News Archive
Biological tissues have evolved over millennia to be perfectly optimized for their specific functions. Take cartilage as an example. It's a compliant, elastic tissue that's soft enough to cushion joints, but strong enough to resist compression and withstand the substantial load bearing of our bodies: key for running, jumping, and our daily wear and tear.
Agriculture Secretary Mike Johanns and Interior Secretary Dirk Kempthorne has announced that their departments and the State of Alaska have tested more than 13,000 wild migratory birds for highly pathogenic avian influenza (HPAI) H5N1 in Alaska.
U.S. health care workers, especially doctors and nurses, use complementary and alternative medicine (CAM) far more than do workers in other fields, according to a new study. CAM includes diverse therapies outside the realm of conventional medicine.
"A summit designed to kickstart a joint effort by world leaders to address hunger and malnutrition will be held in London on 12 August to coincide with the closing day of the Olympics, the British government has announced," the Guardian reports.
Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).
› Verified 4 days ago
Dr. Joseph Kyle Parks, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 127 Village Dr, Suite 300, Belgrade, MT 59714 Phone: 406-388-9661 Fax: 406-388-9662 | |
Advanced Eyecare Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 91 W Madison Ave, Suite B, Belgrade, MT 59714 Phone: 406-388-2488 | |
Joseph Steele Lemay, OD Optometrist Medicare: Medicare Enrolled Practice Location: 91 W Madison Ave, Belgrade, MT 59714 Phone: 406-388-1988 | |
Dr. Kyle D Mcmurray, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 91 W Madison Ave, Ste B, Belgrade, MT 59714 Phone: 406-388-1988 Fax: 406-388-2488 | |
Dr. Jody Lynn Fink, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 91 W Madison Ave, Belgrade, MT 59714 Phone: 406-388-1988 Fax: 406-388-2488 | |
Dr. Douglas J Kimball, DO Optometrist Medicare: Accepting Medicare Assignments Practice Location: 91 W Madison Ave, Suite B, Belgrade, MT 59714 Phone: 406-388-1988 Fax: 406-388-2488 |